Member Info for Kaiver135

Fair point, in hindsight the decision not to launch the service from within the parent company may be a source of lost revenue.

Professor Buckley over on the Polb investor meet presentation, singing the praises of the Hvivo HCS database and its one off uniqueness. Makes you wonder why DiM has not already been spun out.

Very impressed with his contribution, from my perspective, JS sounds as confident as ever in the polb 001 product.

As everyone is aware, raw input data is owned by HVO and available FoC to POolbeg until July 23. Maybe the next question should be "who owns the cleaned up output data?". After all polb will have funded the ai analysis.

Well he was, with the millions of shares being sold in the 9p range, who knows how many he still holds?!!

Ha ha, yes me, been trying to find HVO ticker on google for days??

If the CEO purchase had been printed as a buy, we would have touched 6p today

Why are there no "wouldn't want to be out of this over the weekend" posts. Poor show from the ramping team.

Bit of a no brainer really, share price goes up exeecise the option, if it goes down, let the warrants expire.

Same same, all very straightforward with HL and ii, have funds in the account to cover any extra shares allocated, however I think its highly unlikely people will get much above their entitlement.

Sorry, 0.065p

For every 2 shares you purchase in the OO, you have the option to buy 1 warrant at 0.65p. Note: you can buy the warrants at anytime between OO and 2025 for 0.65p. If you do not wish to buy the warrants, they will expire naturally in 2025, at no cost to you.

Deadline is 15th Aug with both my brokers & share allocation scheduled for 22nd August.

Even though at least 40m of shares bought were posted as sells, my 2m included, I see castle was very keen to point out a 20m sell at 15.49. But then again would expect nothing less from the BB's resident amoeba.

If you actually did some research, you would know the answer to those questions. But then again all your repetitive commentary comes from 1 and 2 year old balance sheets, so unlikely.

From what I have found and linked in, since stoloff resigned as chairman, seek group have 2 employees. Both have financial services backgrounds. One is theMD of peptcell and the other an ex Goldman sachs trader. Interestingly the £1m valuation for Imutex came from a Gloldman Sachs feasibility study.

My understanding is DiM will own the data, companies will pay a subscription/licensing fee to access the datasets they want to use.

Posted by maidit308 on polb board earlier. Influenza v covid 19 in children. Imho this should be right in Orph's sweet spot too.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088615/

My shares are showing as a 20% loss in my H&L ISA. Strange as they were free. :-)

Fair play, you nearly got me to bite. 300 posts in 2 weeks of LSe membership . Good luck with the trolling.